Ambrisentan and aspartate aminotransferase increased 
Ambrisentan and aspartate aminotransferase increased Patient Reports February 11, 2012
Ambrisentan Side Effects Report #5726472-8
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 04, 2008. Female patient, weighting 269.0 lb, was diagnosed with pulmonary hypertension
and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial fibrillation , atrial flutter, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cardiomegaly, gamma-glutamyltransferase increased, hypovolaemia. Ambrisentan dosage: unknown. During the same period patient was treated with SILDENAFIL CITRATE, SILDENAFIL CITRATE, WARFARIN, FUROSEMIDE, LISINOPRIL, DILTIAZEM, GLIPIZIDE, SALSALATE. Patient was hospitalized. Patient recovered.Ambrisentan Side Effects Report #5868256-6
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 25, 2008. Female patient, weighting 250.0 lb, was diagnosed with pulmonary arterial hypertension, embolism, pulmonary hypertension
, oedema and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, gouty tophus, hepatic congestion, hepatomegaly, international normalised ratio increased, oedema peripheral, pain in extremity. Ambrisentan dosage: unknown. During the same period patient was treated with COUMADIN, REVATIO, FUROSEMIDE, SPIRONOLACTONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE, ZAROXOLYN. Patient was hospitalized. Patient recovered.Ambrisentan Side Effects Report #5950484-2
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 30, 2008. Female patient, weighting 250.0 lb, was diagnosed with pulmonary arterial hypertension, embolism, pulmonary hypertension
, oedema and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, international normalised ratio increased, oedema peripheral, right ventricular failure. Ambrisentan dosage: unknown. During the same period patient was treated with COUMADIN, REVATIO, FUROSEMIDE, SPIRONOLACTONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE, ZAROXOLYN. Patient was hospitalized. Patient recovered.Ambrisentan Side Effects Report #5964414-0
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 13, 2008. Female patient, weighting 250.0 lb, was diagnosed with pulmonary arterial hypertension, embolism, pulmonary hypertension
, oedema and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, international normalised ratio increased, oedema peripheral, right ventricular failure. Ambrisentan dosage: unknown. During the same period patient was treated with COUMADIN, REVATIO, FUROSEMIDE, SPIRONOLACTONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE, ZAROXOLYN. Patient was hospitalized. Patient recovered.